Registry for patients using OssDsign® bone grafts in spine fusion

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multi-center, prospective, observational registry aims to collect data on the clinical outcomes and real-world application of OssDsign® bone graft substitutes in patients undergoing spine fusion. The study will involve up to 300 subjects across 10 US sites, with participants followed for 24 months after their surgery. The registry is part of OssDsign®'s post-market surveillance to evaluate the effectiveness and safety of their bone grafts in treating conditions like degenerative disc disease and spinal stenosis.

Why it matters

Who can join: the full rules

* The patient has been diagnosed as a candidate for spinal fusion surgery for which the surgeon has decided an OssDsign® bone graft is appropriate.
* The patient is ≥21 years old.
* The patient is, in the investigator's opinion, psychosocially, mentally, and physically able to fully comply with this protocol, including the post-operative regimen, required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent
* The patient is willing and able to participate in post- operative clinical and radiographic follow up evaluations for 2 years.

Exclusion Criteria:

* Patients not meeting all of the inclusion criteria

Where it's running

• Community Health Partners Neuroscience
  Fresno, California, United States Recruiting
• Memorial Orthopaedic Surgical Group
  Long Beach, California, United States Recruiting
• Orthopedic Associates of Hartford
  Hartford, Connecticut, United States Recruiting
• Central Connecticut Neurosurgery and Spine
  New Britian, Connecticut, United States Recruiting
• Minimally Invasive Spine Center of South Florida
  Miami, Florida, United States Recruiting
• Michigan Orthopaedic Surgeons
  Southfield, Michigan, United States Recruiting

Study contacts

• Study coordinator: jeff Feldhaus
• Email: jfeldhaus@msquaredassociates.com
• Phone: 13476694903

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• New treatment for neuropathic pain in spinal cord injury patients

  This study is testing a new oral medication called EC5026 to see if it can safely help people with spinal cord injuries manage their nerve pain.

  Recruiting Phase 1 EicOsis Human Health Inc. · Augusta, Georgia · NCT06438471

• Registry for patients with personalized spine rods

  This study is testing whether personalized spine rods can help patients who have had spinal surgery feel better and have fewer problems compared to those with standard rods.

  Recruiting University of Colorado, Denver · Aurora, Colorado · NCT04601363

• Evolution of spinal care practices in Bordeaux

  This study will track how care for spine conditions changes over five years by collecting data from adults treated for spinal issues at a Bordeaux hospital.

  Recruiting University Hospital, Bordeaux · Bordeaux · NCT07627282

• PMCF look at METROSAN spinal systems and BONEGRAFT materials in adults after spine surgery

  This PMCF study tests the safety and performance of METROSAN Titania spinal systems and Bonegraft materials in adults undergoing spinal fusion or stabilization in routine practice.

  Recruiting Metrosan End. ve Elk. Mek. Cihazlar ve Tibbi Malz. San. Tic. Ltd. Co. · Izmir and 2 other locations · NCT07615491

• Bone marrow concentrate injection added to lumbar microdiscectomy

  This trial tests whether adding a bone marrow aspirate concentrate injection during lumbar microdiscectomy helps adults recover better than surgery alone.

  Recruiting Weill Medical College of Cornell University · Manhattan, New York · NCT07386548

• IDCT (Intradiscal Cell Therapy) for single-level mild-to-moderate lumbar degenerative disc disease

  This will test whether injecting IDCT (rebonuputemcel) into one degenerating lower-back disc can reduce chronic low back pain in adults with mild-to-moderate lumbar degenerative disc disease.

  Recruiting at 30 sites Phase 3 DiscGenics, Inc. · Birmingham, Alabama and 30 other locations · NCT07254806

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.